Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine

Steffanie Sabbaj, Mark J. Mulligan, Ray Hahn Hsieh, Robert B. Belshe, Jerry R. McGhee, D. Schwartz, D. Burke, Geoffrey J. Gorse, Sharon Frey, Jiri Mestecky, Susan Jackson, John W. Gnann, Paul A. Goepfert, Raphael Dolin, Michael C. Keefer, Thomas G. Evans, M. Julianna McElrath, Lawrence Corey, Barney S. Graham, Peter WrightPaul Spearman, Thomas Matthews, David Montefiori, Kent Weinhold, Dani Bolognesi, Mary Allen, Barbara Savarese

Research output: Contribution to journalArticle

Abstract

Objectives: To study memory T cell proliferative responses and cytokine profiles induced in HIV-1 seronegative volunteers immunized with a live recombinant canarypox vector expressing HIV-1 antigens (ALVAC-HIV) and boosted with a recombinant gp120 subunit vaccine. Design: HIV-specific T cell proliferative responses and cytokines were measured 2 weeks after vaccination. Cytokines secreted by T helper 1 cells (Th1) [interleukin (IL)-2 and interferon-γ (IFN-γ)] and T helper 2 (Th2) cells (IL-4, IL-5, IL-6, and IL-10) were assessed both at the mRNA and the protein level. Methods: Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with HIV antigens. Subsequently, T cell proliferation was measured in a standard lymphoproliferation assay; secreted cytokines were measured using an enzyme-linked immunosorbent assay and upregulation of cytokine mRNA was measured using reverse transcriptase polymerase chain reaction. Results: All individuals who had received ALVAC-HIV followed by the protein vaccine exhibited HIV-1-specific T cell proliferative responses. Moreover, the PBMC of all prime-boost vaccinated individuals produced detectable IFN-γ and IL-10 in response to stimulation with HIV-1 envelope glycoprotein antigens; 83% also had detectable levels of IL-2 and IL-6, 71% had detectable levels of IL-4, and 86% had detectable levels of IL-5. Conclusions: These data indicate that this vaccination regimen was inducing both Th1- and Th2-type responses to HIV-1 envelope antigens. This prime-boost vaccination approach elicited T cell help for the generation of cytotoxic T lymphocyte responses as well as help for antibody production and so promises to generate a broad HIV-1-specific immune response. (C) 2000 Lippincott Williams and Wilkins.

Original languageEnglish (US)
Pages (from-to)1365-1374
Number of pages10
JournalAIDS
Volume14
Issue number10
DOIs
StatePublished - 2000

Fingerprint

AIDS Vaccines
HIV-1
Volunteers
Cytokines
T-Lymphocytes
HIV Antigens
Th1 Cells
Vaccination
Interleukin-5
Interleukin-4
Interleukin-10
Interferons
Interleukin-2
Interleukin-6
Blood Cells
Human Immunodeficiency Virus Proteins
Antigens
Th2 Cells
Messenger RNA
Subunit Vaccines

Keywords

  • Cellular immunity
  • Cytokines
  • T helper lymphocytes
  • Th1/Th2
  • Vaccine

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Sabbaj, S., Mulligan, M. J., Hsieh, R. H., Belshe, R. B., McGhee, J. R., Schwartz, D., ... Savarese, B. (2000). Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. AIDS, 14(10), 1365-1374. https://doi.org/10.1097/00002030-200007070-00009

Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. / Sabbaj, Steffanie; Mulligan, Mark J.; Hsieh, Ray Hahn; Belshe, Robert B.; McGhee, Jerry R.; Schwartz, D.; Burke, D.; Gorse, Geoffrey J.; Frey, Sharon; Mestecky, Jiri; Jackson, Susan; Gnann, John W.; Goepfert, Paul A.; Dolin, Raphael; Keefer, Michael C.; Evans, Thomas G.; McElrath, M. Julianna; Corey, Lawrence; Graham, Barney S.; Wright, Peter; Spearman, Paul; Matthews, Thomas; Montefiori, David; Weinhold, Kent; Bolognesi, Dani; Allen, Mary; Savarese, Barbara.

In: AIDS, Vol. 14, No. 10, 2000, p. 1365-1374.

Research output: Contribution to journalArticle

Sabbaj, S, Mulligan, MJ, Hsieh, RH, Belshe, RB, McGhee, JR, Schwartz, D, Burke, D, Gorse, GJ, Frey, S, Mestecky, J, Jackson, S, Gnann, JW, Goepfert, PA, Dolin, R, Keefer, MC, Evans, TG, McElrath, MJ, Corey, L, Graham, BS, Wright, P, Spearman, P, Matthews, T, Montefiori, D, Weinhold, K, Bolognesi, D, Allen, M & Savarese, B 2000, 'Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine', AIDS, vol. 14, no. 10, pp. 1365-1374. https://doi.org/10.1097/00002030-200007070-00009
Sabbaj, Steffanie ; Mulligan, Mark J. ; Hsieh, Ray Hahn ; Belshe, Robert B. ; McGhee, Jerry R. ; Schwartz, D. ; Burke, D. ; Gorse, Geoffrey J. ; Frey, Sharon ; Mestecky, Jiri ; Jackson, Susan ; Gnann, John W. ; Goepfert, Paul A. ; Dolin, Raphael ; Keefer, Michael C. ; Evans, Thomas G. ; McElrath, M. Julianna ; Corey, Lawrence ; Graham, Barney S. ; Wright, Peter ; Spearman, Paul ; Matthews, Thomas ; Montefiori, David ; Weinhold, Kent ; Bolognesi, Dani ; Allen, Mary ; Savarese, Barbara. / Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine. In: AIDS. 2000 ; Vol. 14, No. 10. pp. 1365-1374.
@article{00bff5cbb71540508e2961e6d45588de,
title = "Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine",
abstract = "Objectives: To study memory T cell proliferative responses and cytokine profiles induced in HIV-1 seronegative volunteers immunized with a live recombinant canarypox vector expressing HIV-1 antigens (ALVAC-HIV) and boosted with a recombinant gp120 subunit vaccine. Design: HIV-specific T cell proliferative responses and cytokines were measured 2 weeks after vaccination. Cytokines secreted by T helper 1 cells (Th1) [interleukin (IL)-2 and interferon-γ (IFN-γ)] and T helper 2 (Th2) cells (IL-4, IL-5, IL-6, and IL-10) were assessed both at the mRNA and the protein level. Methods: Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with HIV antigens. Subsequently, T cell proliferation was measured in a standard lymphoproliferation assay; secreted cytokines were measured using an enzyme-linked immunosorbent assay and upregulation of cytokine mRNA was measured using reverse transcriptase polymerase chain reaction. Results: All individuals who had received ALVAC-HIV followed by the protein vaccine exhibited HIV-1-specific T cell proliferative responses. Moreover, the PBMC of all prime-boost vaccinated individuals produced detectable IFN-γ and IL-10 in response to stimulation with HIV-1 envelope glycoprotein antigens; 83{\%} also had detectable levels of IL-2 and IL-6, 71{\%} had detectable levels of IL-4, and 86{\%} had detectable levels of IL-5. Conclusions: These data indicate that this vaccination regimen was inducing both Th1- and Th2-type responses to HIV-1 envelope antigens. This prime-boost vaccination approach elicited T cell help for the generation of cytotoxic T lymphocyte responses as well as help for antibody production and so promises to generate a broad HIV-1-specific immune response. (C) 2000 Lippincott Williams and Wilkins.",
keywords = "Cellular immunity, Cytokines, T helper lymphocytes, Th1/Th2, Vaccine",
author = "Steffanie Sabbaj and Mulligan, {Mark J.} and Hsieh, {Ray Hahn} and Belshe, {Robert B.} and McGhee, {Jerry R.} and D. Schwartz and D. Burke and Gorse, {Geoffrey J.} and Sharon Frey and Jiri Mestecky and Susan Jackson and Gnann, {John W.} and Goepfert, {Paul A.} and Raphael Dolin and Keefer, {Michael C.} and Evans, {Thomas G.} and McElrath, {M. Julianna} and Lawrence Corey and Graham, {Barney S.} and Peter Wright and Paul Spearman and Thomas Matthews and David Montefiori and Kent Weinhold and Dani Bolognesi and Mary Allen and Barbara Savarese",
year = "2000",
doi = "10.1097/00002030-200007070-00009",
language = "English (US)",
volume = "14",
pages = "1365--1374",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Cytokine profiles in seronegative volunteers immunized with a recombinant canarypox and gp120 prime-boost HIV-1 vaccine

AU - Sabbaj, Steffanie

AU - Mulligan, Mark J.

AU - Hsieh, Ray Hahn

AU - Belshe, Robert B.

AU - McGhee, Jerry R.

AU - Schwartz, D.

AU - Burke, D.

AU - Gorse, Geoffrey J.

AU - Frey, Sharon

AU - Mestecky, Jiri

AU - Jackson, Susan

AU - Gnann, John W.

AU - Goepfert, Paul A.

AU - Dolin, Raphael

AU - Keefer, Michael C.

AU - Evans, Thomas G.

AU - McElrath, M. Julianna

AU - Corey, Lawrence

AU - Graham, Barney S.

AU - Wright, Peter

AU - Spearman, Paul

AU - Matthews, Thomas

AU - Montefiori, David

AU - Weinhold, Kent

AU - Bolognesi, Dani

AU - Allen, Mary

AU - Savarese, Barbara

PY - 2000

Y1 - 2000

N2 - Objectives: To study memory T cell proliferative responses and cytokine profiles induced in HIV-1 seronegative volunteers immunized with a live recombinant canarypox vector expressing HIV-1 antigens (ALVAC-HIV) and boosted with a recombinant gp120 subunit vaccine. Design: HIV-specific T cell proliferative responses and cytokines were measured 2 weeks after vaccination. Cytokines secreted by T helper 1 cells (Th1) [interleukin (IL)-2 and interferon-γ (IFN-γ)] and T helper 2 (Th2) cells (IL-4, IL-5, IL-6, and IL-10) were assessed both at the mRNA and the protein level. Methods: Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with HIV antigens. Subsequently, T cell proliferation was measured in a standard lymphoproliferation assay; secreted cytokines were measured using an enzyme-linked immunosorbent assay and upregulation of cytokine mRNA was measured using reverse transcriptase polymerase chain reaction. Results: All individuals who had received ALVAC-HIV followed by the protein vaccine exhibited HIV-1-specific T cell proliferative responses. Moreover, the PBMC of all prime-boost vaccinated individuals produced detectable IFN-γ and IL-10 in response to stimulation with HIV-1 envelope glycoprotein antigens; 83% also had detectable levels of IL-2 and IL-6, 71% had detectable levels of IL-4, and 86% had detectable levels of IL-5. Conclusions: These data indicate that this vaccination regimen was inducing both Th1- and Th2-type responses to HIV-1 envelope antigens. This prime-boost vaccination approach elicited T cell help for the generation of cytotoxic T lymphocyte responses as well as help for antibody production and so promises to generate a broad HIV-1-specific immune response. (C) 2000 Lippincott Williams and Wilkins.

AB - Objectives: To study memory T cell proliferative responses and cytokine profiles induced in HIV-1 seronegative volunteers immunized with a live recombinant canarypox vector expressing HIV-1 antigens (ALVAC-HIV) and boosted with a recombinant gp120 subunit vaccine. Design: HIV-specific T cell proliferative responses and cytokines were measured 2 weeks after vaccination. Cytokines secreted by T helper 1 cells (Th1) [interleukin (IL)-2 and interferon-γ (IFN-γ)] and T helper 2 (Th2) cells (IL-4, IL-5, IL-6, and IL-10) were assessed both at the mRNA and the protein level. Methods: Peripheral blood mononuclear cells (PBMC) were stimulated in vitro with HIV antigens. Subsequently, T cell proliferation was measured in a standard lymphoproliferation assay; secreted cytokines were measured using an enzyme-linked immunosorbent assay and upregulation of cytokine mRNA was measured using reverse transcriptase polymerase chain reaction. Results: All individuals who had received ALVAC-HIV followed by the protein vaccine exhibited HIV-1-specific T cell proliferative responses. Moreover, the PBMC of all prime-boost vaccinated individuals produced detectable IFN-γ and IL-10 in response to stimulation with HIV-1 envelope glycoprotein antigens; 83% also had detectable levels of IL-2 and IL-6, 71% had detectable levels of IL-4, and 86% had detectable levels of IL-5. Conclusions: These data indicate that this vaccination regimen was inducing both Th1- and Th2-type responses to HIV-1 envelope antigens. This prime-boost vaccination approach elicited T cell help for the generation of cytotoxic T lymphocyte responses as well as help for antibody production and so promises to generate a broad HIV-1-specific immune response. (C) 2000 Lippincott Williams and Wilkins.

KW - Cellular immunity

KW - Cytokines

KW - T helper lymphocytes

KW - Th1/Th2

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=0033939889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033939889&partnerID=8YFLogxK

U2 - 10.1097/00002030-200007070-00009

DO - 10.1097/00002030-200007070-00009

M3 - Article

C2 - 10930151

AN - SCOPUS:0033939889

VL - 14

SP - 1365

EP - 1374

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - 10

ER -